Overview

Drug-Drug Interaction Study of Vadadustat With Rosuvastatin, Sulfasalazine, Pravastatin, Atorvastatin and Simvastatin

Status:
Completed
Trial end date:
2018-11-24
Target enrollment:
Participant gender:
Summary
This is a Phase 1, three-part, open-label study to evaluate vadadustat as a perpetrator in drug-drug interactions with rosuvastatin, sulfasalazine, pravastatin, atorvastatin and simvastatin in healthy male and female subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Akebia Therapeutics
Treatments:
Atorvastatin
Atorvastatin Calcium
Pravastatin
Rosuvastatin Calcium
Simvastatin
Sulfasalazine